DDX3 AS A BIOMARKER FOR CANCER AND METHODS RELATED THERETO

The invention encompasses methods for treating or preventing diseases and disorders associated abnormal cell growth, for example, treating or preventing cancer or tumor growth, by administering to a subject in need thereof a composition comprising a therapeutically or prophylactically effective amou...

Full description

Saved in:
Bibliographic Details
Main Authors RAMAN, VENU, BOL, GUUS, MARTINUS, VAN DIEST, PAUL, JOANNES
Format Patent
LanguageEnglish
French
Published 25.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention encompasses methods for treating or preventing diseases and disorders associated abnormal cell growth, for example, treating or preventing cancer or tumor growth, by administering to a subject in need thereof a composition comprising a therapeutically or prophylactically effective amount of a compound that downregulates DDX3, for example a fused diimidazodiazepine ring compound or a pharmaceutically acceptable salt thereof. The invention also encompasses the use of DDX3 as a biomarker for diagnostic and treatment purposes, for example, to identify a hyperproliferative disorder susceptible to treatment by down regulation of DDX3.
AbstractList The invention encompasses methods for treating or preventing diseases and disorders associated abnormal cell growth, for example, treating or preventing cancer or tumor growth, by administering to a subject in need thereof a composition comprising a therapeutically or prophylactically effective amount of a compound that downregulates DDX3, for example a fused diimidazodiazepine ring compound or a pharmaceutically acceptable salt thereof. The invention also encompasses the use of DDX3 as a biomarker for diagnostic and treatment purposes, for example, to identify a hyperproliferative disorder susceptible to treatment by down regulation of DDX3.
Author VAN DIEST, PAUL, JOANNES
RAMAN, VENU
BOL, GUUS, MARTINUS
Author_xml – fullname: RAMAN, VENU
– fullname: BOL, GUUS, MARTINUS
– fullname: VAN DIEST, PAUL, JOANNES
BookMark eNrjYmDJy89L5WSwcnGJMFZwDFZwVHDy9Pd1DPJ2DVJw8w9ScHb0cwYyHf1cFHxdQzz8XYIVglx9HENcXRRCPFyDXEP8eRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGhiaGJpYGFiaORMXGqAA45Kw0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DDX3 SERVANT DE BIOMARQUEUR POUR LE CANCER ET MÉTHODES ASSOCIÉES
ExternalDocumentID WO2014149084A2
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2014149084A23
IEDL.DBID EVB
IngestDate Fri Jul 19 16:01:18 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2014149084A23
Notes Application Number: WO2013US71021
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140925&DB=EPODOC&CC=WO&NR=2014149084A2
ParticipantIDs epo_espacenet_WO2014149084A2
PublicationCentury 2000
PublicationDate 20140925
PublicationDateYYYYMMDD 2014-09-25
PublicationDate_xml – month: 09
  year: 2014
  text: 20140925
  day: 25
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies THE JOHNS HOPKINS UNIVERSITY
RelatedCompanies_xml – name: THE JOHNS HOPKINS UNIVERSITY
Score 2.9556549
Snippet The invention encompasses methods for treating or preventing diseases and disorders associated abnormal cell growth, for example, treating or preventing cancer...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title DDX3 AS A BIOMARKER FOR CANCER AND METHODS RELATED THERETO
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140925&DB=EPODOC&locale=&CC=WO&NR=2014149084A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt6L9sq0wpG1SqtJ2dFX3NvoRQZBuuIr_vpfQ6Z72luTgSAK_u1zuC-Da5WVRcK1QUT46ooVZqbq1KIRs1hY3SutWexcJznFyF72YT1Nr2oPPVS6MrBP6I4sjIqIqxHsr5fXi_xOLytjK5U35gUvzhzAfUaWzjkX1Jt1SqD9i45SmgRIEaLcpSSZpmnBymR4K7C18SNsCD-zVF3kpi3WlEu7D9hj5Ne0B9HgzgN1g1XttADtx5_LGYYe-5SHcUzo1iDchHvEf09jLnllG0IojgegwkxEvoSRmeZTSCRGtMFAokTxiGcvTI7gKWR5EKm5i9nfm2Vu6vmPjGPrNvOEnQJxCF45b26n02qzqunBcXhkmR0XNddvSTmG4idPZZvI57ImpCIjQrSH0269vfoFaty0v5WX9AjhFfwk
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8NADA9jivNNp-LH1AOlb0X75TphSNu70bm1N7qqeyv9OEGQbriK_765sume9nZcIOQOklwuyS8Atz2RpanQUhXtoy1HmGVqr5BAyGZhCSOz7rV32eAchA_-i_k8s2YN-Fz3wtQ4oT81OCJqVI76XtX2evH_iUXr2srlXfaBW_OnQdynyio6luhNuqVQt88mnHJP8TyM25QwqmmaTHKZDhrsHXxkd6U-sFdX9qUsNp3K4AB2J8ivrA6hIco2tLz17LU27AWrlDcuV9q3PIJHSmcGcabEIe6QB040YhHBKI54csJMRJyQkoDFPqdTIkdhoFEisc8iFvNjuBmw2PNVFCL5O3PyxjclNk6gWc5LcQrETnWZuO3auV6YeVGkdk_khinQUQu9a2ln0NnG6Xw7-RpafhyMk_EwHF3AviTJ4gjd6kCz-voWl-iBq-yqvrhfWNqB_A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DDX3+AS+A+BIOMARKER+FOR+CANCER+AND+METHODS+RELATED+THERETO&rft.inventor=RAMAN%2C+VENU&rft.inventor=BOL%2C+GUUS%2C+MARTINUS&rft.inventor=VAN+DIEST%2C+PAUL%2C+JOANNES&rft.date=2014-09-25&rft.externalDBID=A2&rft.externalDocID=WO2014149084A2